Cargando…

BRCA-Mutated Pancreatic Cancer: From Discovery to Novel Treatment Paradigms

SIMPLE SUMMARY: Approximately 10–20% of pancreatic cancer patients will have a mutation in their DNA, passed on in families, that contributes to the development of their pancreatic cancer. These mutations are important in that they effect the biology of the disease as well as contribute to sensitivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Devico Marciano, Naomie, Kroening, Gianna, Dayyani, Farshid, Zell, Jason A., Lee, Fa-Chyi, Cho, May, Valerin, Jennifer Goldstein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140002/
https://www.ncbi.nlm.nih.gov/pubmed/35626055
http://dx.doi.org/10.3390/cancers14102453